Literature DB >> 23903569

Pathway for approval of a gene therapy orphan product: treading new ground.

Barry J Byrne.   

Abstract

Mesh：

Year:  2013        PMID： 23903569      PMCID： PMC3734657          DOI： 10.1038/mt.2013.157

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  1 in total

1.  Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012.

Authors:  Marina O'Reilly; Donald B Kohn; Jeffrey Bartlett; Janet Benson; Philip J Brooks; Barry J Byrne; Carlos Camozzi; Kenneth Cornetta; Ronald G Crystal; Yuman Fong; Linda Gargiulo; Rashmi Gopal-Srivastava; Katherine A High; Samuel G Jacobson; Robert C Jambou; Maureen Montgomery; Eugene Rosenthal; R Jude Samulski; Sonia I Skarlatos; Brian Sorrentino; James M Wilson; Yun Xie; Jacqueline Corrigan-Curay
Journal:  Hum Gene Ther       Date:  2013-04       Impact factor: 5.695
  1 in total
  3 in total

1.  Microtubule defects & Neurodegeneration.

Authors:  Fiona J Baird; Craig L Bennett
Journal:  J Genet Syndr Gene Ther       Date:  2013-12-06

Review 2.  Gene therapy for inherited muscle diseases: where genetics meets rehabilitation medicine.

Authors:  Robynne Braun; Zejing Wang; David L Mack; Martin K Childers
Journal:  Am J Phys Med Rehabil       Date:  2014-11       Impact factor: 2.159

Review 3.  The future potential for cocaine vaccines.

Authors:  Frank M Orson; Rongfu Wang; Stephen Brimijoin; Berma M Kinsey; Rana Ak Singh; Muthu Ramakrishnan; Helen Y Wang; Thomas R Kosten
Journal:  Expert Opin Biol Ther       Date:  2014-05-16       Impact factor: 4.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.